Nonlinearity of dose-response functions for carcinogenicity.

Carcinogenesis data for 315 chemicals were obtained from the National Cancer Institute-National Toxicology Program (NCI-NTP) bioassay programs and were analyzed to examine the shape of carcinogenesis dose-response curves. Tumor site data were more often consistent with a quadratic response than with a linear response, suggesting that the routine use of linear dose-response models will often overestimate risk. Information from in vivo short-term mutagenicity and genotoxicity assays was also obtained for most of these rodent bioassays. It was found that there were no clear relationships between the shape of the carcinogenesis dose-response curve and the result of the short-term test. These observations argue against the concept that carcinogens that are positive in a short-term assay be regulated using a linear dose-response curve and those that are negative be regulated using a sublinear dose-response curve or a safety factor approach.

[1]  W. Stott,et al.  Genetic and nongenetic events in neoplasia. , 1981, Food and cosmetics toxicology.

[2]  B. Ponder,et al.  Molecular Genetics of Cancer , 1992, Nature Medicine.

[3]  R. Weinberg,et al.  The action of oncogenes in the cytoplasm and nucleus. , 1985, Science.

[4]  S H Moolgavkar,et al.  Mutation and cancer: a model for human carcinogenesis. , 1981, Journal of the National Cancer Institute.

[5]  R. Albert,et al.  Approach to risk assessment for genotoxic carcinogens based on data from the mouse skin initiation-promotion model. , 1983, Environmental health perspectives.

[6]  A Kopp-Schneider,et al.  A multistage model of carcinogenesis incorporating DNA damage and repair. , 1991, Risk analysis : an official publication of the Society for Risk Analysis.

[7]  J C Bailar,et al.  One-hit models of carcinogenesis: conservative or not? , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[8]  W. Flamm,et al.  Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens. , 1986, Environmental health perspectives.

[9]  C. Portier,et al.  Biologically based models for risk assessment. , 1990, IARC scientific publications.

[10]  F P Perera,et al.  The genotoxic/epigenetic distinction: relevance to cancer policy. , 1984, Environmental research.

[11]  D. Preston,et al.  Dose-Response in Radiation Carcinogenesis: Animal Studies , 1985 .

[12]  A J Bailer,et al.  Testing for increased carcinogenicity using a survival-adjusted quantal response test. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[13]  J. Barrett,et al.  Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment. , 1987, Environmental health perspectives.

[14]  J. Cornfield,et al.  Carcinogenic risk assessment. , 1977, Science.

[15]  B. Ames,et al.  Too many rodent carcinogens: mitogenesis increases mutagenesis. , 1990, Science.

[16]  L. Ellwein,et al.  Cell proliferation in carcinogenesis. , 1990, Science.

[17]  Bailer Aj,et al.  Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. , 1988 .

[18]  A J Bailer,et al.  Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. , 1988, Biometrics.

[19]  M Gough,et al.  Science policy choices and the estimation of cancer risk associated with exposure to TCDD. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[20]  F. A. Smith,et al.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.

[21]  R. Weinberg,et al.  Cellular oncogenes and multistep carcinogenesis. , 1983, Science.

[22]  T. Slaga,et al.  Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[23]  N Mantel,et al.  Estimating "safe" levels, a hazardous undertaking. , 1975, Cancer research.

[24]  R. Newbold,et al.  Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene , 1983, Nature.

[25]  S. Belinsky,et al.  Cell selective alkylation of DNA in rat lung following low dose exposure to the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. , 1987, Cancer research.

[26]  J H Weisburger,et al.  Carcinogen testing: current problems and new approaches. , 1981, Science.

[27]  D G Hoel,et al.  Implication of nonlinear kinetics on risk estimation in carcinogenesis. , 1983, Science.